See more : Premier Graphene Inc (BIEI) Income Statement Analysis – Financial Results
Complete financial analysis of Columbia Care Inc. (CCHWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Columbia Care Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- ASUTOSH ENTERPRISES LTD. (ASUTENT.BO) Income Statement Analysis – Financial Results
- R J BIO-TECH LTD (RJBIOTECH.BO) Income Statement Analysis – Financial Results
- Suzhou SLAC Precision Equipment CO.,Ltd. (300382.SZ) Income Statement Analysis – Financial Results
- Entheon Biomedical Corp. (ENBI.CN) Income Statement Analysis – Financial Results
- The Greater Cannabis Company, Inc. (GCAN) Income Statement Analysis – Financial Results
Columbia Care Inc. (CCHWF)
About Columbia Care Inc.
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 511.58M | 460.08M | 179.50M | 77.46M | 0.00 |
| Cost of Revenue | 310.37M | 266.07M | 113.53M | 40.60M | 0.00 |
| Gross Profit | 201.21M | 194.02M | 65.98M | 36.86M | 0.00 |
| Gross Profit Ratio | 39.33% | 42.17% | 36.76% | 47.59% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 203.69M | 179.48M | 118.34M | 105.44M | 0.00 |
| Selling & Marketing | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
| SG&A | 617.45M | 195.73M | 124.42M | 111.24M | 0.00 |
| Other Expenses | -16.45M | 36.32M | 15.65M | 7.45M | 0.00 |
| Operating Expenses | 617.45M | 232.05M | 140.07M | 118.68M | 0.00 |
| Cost & Expenses | 927.82M | 498.12M | 253.60M | 159.28M | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 53.90M | 30.01M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 84.79M | 53.00M | 42.02M | 26.26M | 161.14K |
| EBITDA | -416.24M | 13.64M | -32.08M | -55.56M | 0.00 |
| EBITDA Ratio | -81.36% | 2.96% | -17.87% | -71.73% | 0.00% |
| Operating Income | -416.24M | -39.37M | -74.10M | -81.82M | 0.00 |
| Operating Income Ratio | -81.36% | -8.56% | -41.28% | -105.63% | 0.00% |
| Total Other Income/Expenses | -16.45M | -107.35M | -62.77M | -12.04M | 0.00 |
| Income Before Tax | -432.69M | -146.71M | -136.87M | -93.85M | 0.00 |
| Income Before Tax Ratio | -84.58% | -31.89% | -76.25% | -121.17% | 0.00% |
| Income Tax Expense | -11.21M | 139.00K | -3.67M | 12.87M | 0.00 |
| Net Income | -421.48M | -146.85M | -133.20M | -106.73M | 0.00 |
| Net Income Ratio | -82.39% | -31.92% | -74.20% | -137.79% | 0.00% |
| EPS | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
| EPS Diluted | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
| Weighted Avg Shares Out | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
| Weighted Avg Shares Out (Dil) | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
Nasdaq Bear Market: 5 Fantastic Growth Stocks You'll Regret Not Buying On the Dip
These transformative growth stocks are begging to be bought following a 34% peak decline in the Nasdaq.
3 Marijuana Stocks To Keep On Your Radar Come August
3 Marijuana Stocks To Watch Next Month The post 3 Marijuana Stocks To Keep On Your Radar Come August appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Don't Rule Out A Bull Market
Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism.
Top Cannabis Stocks To Buy? 3 To Watch As Sector Experiences Momentum
Are Top Pot Stocks On Your Watchlist For August? The post Top Cannabis Stocks To Buy? 3 To Watch As Sector Experiences Momentum appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Cresco Labs Is Risky Like All Cannabis Stocks
Cannabis stocks imploded after showing great promise. We remain bullish for the long-term on Cresco Labs and for the future of the American marijuana industry. The shares will hover around $3 for the next few quarters until the financial picture from...
3 Marijuana Stocks To Keep On Watch This Month
Marijuana Stocks To Watch For Better Trading In July The post 3 Marijuana Stocks To Keep On Watch This Month appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
3 Marijuana Stocks To Buy In July?
3 Marijuana Stocks To Watch Next Month The post 3 Marijuana Stocks To Buy In July? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Top Cannabis Penny Stocks Under $2 Right Now
Penny Pot Stocks For July 2022 The post Top Cannabis Penny Stocks Under $2 Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Cannabis REITs: Weeding Out The Weak
Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real...
Top Marijuana Stocks To Buy? 3 Companies To Keep On Your Radar
Top Marijuana Stocks To Watch For Better Trading In 2022 The post Top Marijuana Stocks To Buy? 3 Companies To Keep On Your Radar appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Source: https://incomestatements.info
Category: Stock Reports